 regeneron pharmaceuticals inc nasdaqregn svp michael s aberman sells  shares  bnb daily daily ratings  news for regeneron pharmaceuticals inc complete the form below to receive the latest headlines and analysts recommendationsfor regeneron pharmaceuticals inc with our free daily email newsletter follow bnbdailynews recent posts renault sa’s rno “buy” rating reaffirmed at deutsche bank ag adamas pharmaceuticals inc adms upgraded to “hold” by zacks investment research daniel e bachus sells  shares of grand canyon education inc lope stock papa murphy’s holdings inc nasdaqfrsh major shareholder mfp partners lp acquires  shares vernalis plc vnlpy raised to buy at zacks investment research zacks investment research downgrades yingli green energy holding company limited yge to sell man group plc otcmktsmngpy receives consensus rating of “buy” from analysts regeneron pharmaceuticals inc nasdaqregn svp michael s aberman sells  shares natera nasdaqntra receives media impact score of  almost family nasdaqafam receives daily news sentiment rating of  atara biotherapeutics nasdaqatra earns news impact rating of  morg stan asia nyseapf receiving positive media coverage analysis shows chicago trust co na has  million stake in harleydavidson inc hog zacks investment research upgrades biodel inc albo to buy healthequity inc hqy receives  consensus pt from analysts boralex inc blx given consensus recommendation of “buy” by analysts charter communications inc chtr shares sold by private capital advisors inc zacks yirendai ltd nyseyrd receives consensus rating of “hold” from brokerages principal financial group inc pfg evp karen e shaff sells  shares principal financial group inc pfg svp gregory bernard elming sells  shares regeneron pharmaceuticals inc nasdaqregn svp michael s aberman sells  shares posted by dan jones on jul nd   no comments regeneron pharmaceuticals inc nasdaqregn svp michael s aberman sold  shares of the company’s stock in a transaction dated thursday june nd the stock was sold at an average price of  for a total value of  following the completion of the transaction the senior vice president now directly owns  shares of the company’s stock valued at approximately  the transaction was disclosed in a filing with the sec which is available at the sec website regeneron pharmaceuticals inc regn traded down  during trading on friday reaching  the company had a trading volume of  shares the stock has a  day moving average price of  and a day moving average price of  the company has a market capitalization of  billion a pe ratio of  and a beta of  regeneron pharmaceuticals inc has a week low of  and a week high of  regeneron pharmaceuticals nasdaqregn last posted its earnings results on thursday may th the biopharmaceutical company reported  earnings per share for the quarter beating the thomson reuters’ consensus estimate of  by  regeneron pharmaceuticals had a net margin of  and a return on equity of  the business had revenue of  billion for the quarter compared to analyst estimates of  billion during the same quarter in the previous year the business posted  eps the business’s quarterly revenue was up  on a yearoveryear basis on average equities research analysts anticipate that regeneron pharmaceuticals inc will post  earnings per share for the current fiscal year get regeneron pharmaceuticals inc alerts warning this piece was posted by bnb daily and is the property of of bnb daily if you are accessing this piece on another website it was illegally stolen and reposted in violation of united states  international trademark  copyright law the legal version of this piece can be accessed at httpswwwbaseballnewsblogcommichaelsabermansellssharesofregeneronpharmaceuticalsincregnstockupdatedupdatedhtml institutional investors have recently modified their holdings of the company korea investment corp raised its position in shares of regeneron pharmaceuticals by  in the first quarter korea investment corp now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares in the last quarter wfg advisors lp raised its position in shares of regeneron pharmaceuticals by  in the fourth quarter wfg advisors lp now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares in the last quarter fny managed accounts llc purchased a new position in shares of regeneron pharmaceuticals during the first quarter worth approximately  alpha windward llc raised its position in shares of regeneron pharmaceuticals by  in the first quarter alpha windward llc now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares in the last quarter finally wendell david associates inc purchased a new position in shares of regeneron pharmaceuticals during the second quarter worth approximately  hedge funds and other institutional investors own  of the company’s stock a number of equities analysts recently weighed in on regn shares sanford c bernstein reaffirmed an “outperform” rating on shares of regeneron pharmaceuticals in a report on thursday may th canaccord genuity reaffirmed a “hold” rating and issued a  price target on shares of regeneron pharmaceuticals in a report on thursday march th bmo capital markets reaffirmed a “hold” rating and issued a  price target up previously from  on shares of regeneron pharmaceuticals in a report on tuesday march th leerink swann reiterated an “outperform” rating and set a  price objective on shares of regeneron pharmaceuticals in a research note on tuesday june th finally bidaskclub upgraded regeneron pharmaceuticals from a “buy” rating to a “strongbuy” rating in a research report on saturday june th one analyst has rated the stock with a sell rating sixteen have given a hold rating and thirteen have assigned a buy rating to the stock the stock has an average rating of “hold” and a consensus price target of  regeneron pharmaceuticals company profile regeneron pharmaceuticals inc is a biopharmaceutical company that discovers invents develops manufactures and commercializes medicines for the treatment of serious medical conditions the company commercializes medicines for eye diseases high lowdensity lipoprotein ldl cholesterol and an inflammatory condition and have product candidates in development in other areas including rheumatoid arthritis asthma atopic dermatitis pain cancer and infectious diseases receive news  ratings for regeneron pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for regeneron pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website regn michael s aberman insider trades for regeneron pharmaceuticals inc bulletin investor alert tokyo markets open in us market snapshot currencies commodities expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close regeneron pharmaceuticals inc nasdaq regn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus regeneron pharmaceuticals inc after hours  quotes are delayed by  min jul    pm regn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   insider activity individual michael s aberman dr michael s aberman md mba is vice presidentstrategy  investor relations at regeneron pharmaceuticals inc dr aberman was previously employed as a research analyst by credit suisse securities a research associate by morgan stanley  co inc and a directorbusiness development by antigenics inc he received his undergraduate degree from cornell university an mba from the wharton school of the university of pennsylvania and a doctorate degree from the university of toronto transactions date shares transaction value     disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr p roy vagelos chairman dr leonard s schleifer president chief executive officer  director mr robert e landry chief financial officer  senior vpfinance dr george damis yancopoulos director  chief scientific officer dr peter powchik senior vice presidentclinical development dr neil stahl executive vpresearch  development ms beth f levine senior vice president  chief compliance officer dr jay s markowitz senior vice presidentportfolio management mr robert j terifay senior vice presidentcommercial dr janet van adelsberg senior directorimmunology  inflammation dr alan shuldiner vice presidenttranslational genetics mr daniel p van plew svp gmindustrial operations  product supply dr n anthony coles director dr huda y zoghbi director dr bonnie l bassler director mr christopher fenimore chief accounting officer vp  controller mr potoula gjidija headmedia contacts ms hala mirza headcorporate communications dr manisha a narasimhan investor relations contact dr michael s aberman senior vpstrategy  investor relations ms sally a paull senior vice presidenthuman resources mr joseph j larosa secretary senior vice president  general counsel dr ned braunstein senior vice presidentregulatory affairs dr marc tessierlavigne independent director ms christine a poon independent director mr arthur frederick ryan independent director mr george l sing independent director dr joseph l goldstein independent director mr charles a baker independent director dr michael s brown independent class i director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwsj interview trump doesnt rule out firing sessions pformer trump campaign chief manafort strikes deal to avoid public testimony pone depressing reason millions of people are locked out of the american dream phouse votes to prevent disgruntled customers from being able to sue their bank ppaypal earnings a boost from partnerships but are the benefits already priced in pthis quant pro and card counter says gambling can make you a better investor pbitcoin digital currencies retreat from records pthis is what it will take for bitcoin to become a legit currency pemerging markets fund manager favors bangladesh and kenya and avoids korea and taiwan puss thunderbolt fires warning shots at iranian vessel in gulf phere’s one trump fan who might make you some money pchegg shares sink after secondquarter loss pmccain returns to senate with strong comments on health care puniversal health services shares drop on earnings outlook pwhy you should avoid jared kushner’s weirdly casual approach to meetings phealthcare debate moves forward in senate phere’s why oil just scored its biggest oneday rally of  pusana health sciences shares drop after company misses earnings cuts outlook pwells fargo raises dividend by  to  cents a share pwhy oil prices scored their biggest oneday rally of  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  michael s aberman sells  shares of regeneron pharmaceuticals inc regn stock  american banking news home get email updates about disclaimer contact privacy policy   business news us news world news stock ratings analysts upgrades analysts downgrades analysts eps estimates analysts price targets analysts new coverage corporate earnings earnings results earnings guidance earnings previews dividends insider trades options press releases regeneron pharmaceuticals inc  get news  ratings daily enter your email address below to get the latest news and analysts ratings for regeneron pharmaceuticals inc with our free daily email newsletter recent stories investment analysts’ recent ratings changes for lumentum holdings lite ollies bargain outlet holdings inc nasdaqolli given average rating of “buy” by analysts chimera investment corporation cim receives consensus recommendation of “hold” from analysts nu skin enterprises inc nysenus receives average recommendation of “hold” from brokerages stifel nicolaus reaffirms hold rating for cott corporation cot tcf financial corporation tcf given “hold” rating at deutsche bank ag lennar corporation’s len “buy” rating reiterated at argus western digital corporation’s nasdaqwdc outperform rating reaffirmed at cowen and company first solar inc fslr given outperform rating at cowen and company halliburton company nysehal receives buy rating from ubs ag td ameritrade holding corporation nasdaqamtd earns “equal weight” rating from morgan stanley cliffs natural resources’ nyseclf sell rating reaffirmed at axiom securities heidrick  struggles international inc hsii rating reiterated by deutsche bank ag werner enterprises’ wern overweight rating reaffirmed at morgan stanley united states steel corporation nysex stock rating reaffirmed by axiom securities workiva inc nysewk receives “equal weight” rating from morgan stanley synchrony financial syf receives “overweight” rating from morgan stanley macquarie reiterates outperform rating for vf corporation vfc jefferies group llc reiterates “buy” rating for radisys corporation nasdaqrsys nexgen energy ltd nysenxe sees large increase in short interest michael s aberman sells  shares of regeneron pharmaceuticals inc regn stock june rd  •  comments • filed under • by abmn staff filed under insider trades • market news tweet regeneron pharmaceuticals inc nasdaqregn svp michael s aberman sold  shares of the stock in a transaction dated thursday june nd the stock was sold at an average price of  for a total transaction of  following the transaction the senior vice president now directly owns  shares in the company valued at approximately  the sale was disclosed in a document filed with the securities  exchange commission which is accessible through this hyperlink shares of regeneron pharmaceuticals inc nasdaq regn traded down  during midday trading on friday reaching   shares of the company were exchanged regeneron pharmaceuticals inc has a  month low of  and a  month high of  the firm has a day moving average price of  and a  day moving average price of  the stock has a market capitalization of  billion a pe ratio of  and a beta of  regeneron pharmaceuticals also was the target of unusually large options trading activity on friday traders acquired  put options on the company this is an increase of  compared to the average daily volume of  put options get regeneron pharmaceuticals inc alerts regeneron pharmaceuticals nasdaqregn last posted its quarterly earnings results on thursday may th the biopharmaceutical company reported  earnings per share for the quarter topping the zacks’ consensus estimate of  by  the business had revenue of  billion during the quarter compared to the consensus estimate of  billion regeneron pharmaceuticals had a net margin of  and a return on equity of  regeneron pharmaceuticals’s revenue for the quarter was up  compared to the same quarter last year during the same period in the previous year the firm posted  earnings per share equities research analysts anticipate that regeneron pharmaceuticals inc will post  eps for the current fiscal year copyright violation notice this piece of content was first reported by american banking news and is owned by of american banking news if you are reading this piece of content on another publication it was stolen and reposted in violation of us and international trademark and copyright legislation the correct version of this piece of content can be viewed at httpswwwamericanbankingnewscommichaelsabermansellssharesofregeneronpharmaceuticalsincregnstockhtml several brokerages have recently commented on regn leerink swann reaffirmed an “outperform” rating on shares of regeneron pharmaceuticals in a research report on thursday raymond james financial inc reaffirmed an “outperform” rating on shares of regeneron pharmaceuticals in a research report on thursday canaccord genuity set a  price target on shares of regeneron pharmaceuticals and gave the stock a “buy” rating in a research report on tuesday bmo capital markets reaffirmed a “market perform” rating and set a  price target on shares of regeneron pharmaceuticals in a research report on wednesday finally oppenheimer holdings inc reaffirmed a “hold” rating on shares of regeneron pharmaceuticals in a research report on wednesday june th one investment analyst has rated the stock with a sell rating thirteen have given a hold rating and thirteen have issued a buy rating to the company’s stock the company has a consensus rating of “hold” and an average target price of  large investors have recently bought and sold shares of the company blackrock inc increased its stake in regeneron pharmaceuticals by  in the first quarter blackrock inc now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period wellington management group llp increased its stake in regeneron pharmaceuticals by  in the first quarter wellington management group llp now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period vanguard group inc increased its stake in regeneron pharmaceuticals by  in the first quarter vanguard group inc now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period state street corp increased its stake in regeneron pharmaceuticals by  in the first quarter state street corp now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period finally artisan partners limited partnership increased its stake in regeneron pharmaceuticals by  in the first quarter artisan partners limited partnership now owns  shares of the biopharmaceutical company’s stock worth  after buying an additional  shares during the period  of the stock is owned by institutional investors and hedge funds about regeneron pharmaceuticals regeneron pharmaceuticals inc is a biopharmaceutical company that discovers invents develops manufactures and commercializes medicines for the treatment of serious medical conditions the company commercializes medicines for eye diseases high lowdensity lipoprotein ldl cholesterol and an inflammatory condition and have product candidates in development in other areas including rheumatoid arthritis asthma atopic dermatitis pain cancer and infectious diseases receive news  ratings for regeneron pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for regeneron pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter leave a reply click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation  copyright american banking and market news  all rights reserved privacy policy and disclosures  about  advertising  contact content on this website is not meant to be a recommendation or an offer to buy or sell any security click here to read our full disclaimer michael s aberman of regeneron pharmaceuticals inc executive profile   welcome company news company site premium log in membership home portfolio stocks bonds funds etfs cef markets tools real life finance discuss investing ideas fund analyst picks picks by category fund pick performance picks  pans enewsletter fund spy column fund spy book bond squad fund video reports fundinvestor newsletter etf investing fund family experts fund reports all fund analyst reports fund stewardship reports fund ratings highestrated value highestrated growth highestrated largecap highestrated midcap highestrated smallcap foreign fund standouts star rating performance rating methodology fund performance top month performers top ytd performers top year performers top year performers top year performers fund category returns biggest daily nav changes closedend funds exchangetraded funds quarterly market outlook fund screeners basic screeners fund screener longterm winners solid smallgrowth funds conservative bond funds premium screeners premium fund screener index funds hidden gems lowerrisk foreign funds video center regeneron pharmaceuticals inc  regn add to portfolioget email alertsprint this pagepdf reportdata questionquotechartstock analysisperformancekey ratiosfinancialsvaluationinsidersownershipfilingsbondsoverviewexecutive compensationinsider activitykey executivesboard of directorscommittees key executives  michael s aberman michael s aberman senior vice president strategy and investor relations profile connections biography dr michael s abermanmd  has been senior vice president strategy and investor relations since january  from march  to december  he served as vice president strategy and investor relations prior to joining the company he spent six years as a wall street analyst covering the biotechnology industry from march  until joining the company he was director and senior biotechnology analyst at credit suisse prior to that from march  until march  he worked as a biotechnology analyst at morgan stanley inc from february  through march  dr aberman was director of business development at antigenics inc an oncologyfocused biotechnology company dr aberman received his md with honors from the university of toronto and his mba from the wharton school of the university of pennsylvania board membership michael s aberman is not a member of any boards   we value your feedback let us know what you think site directory site map our products corrections help advertising opportunities licensing opportunities glossary rss mobile portfolio affiliate careers international sites australia canada china france germany hong kong italy the netherlands norway spain uk switzerland stocks by name  ticker  star rating  market cap  stock type  sector  industry mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name etfs by star rating  category  total assets  symbol  ticker  name articles by title  date  author  collection  interest  popularity investment categories by topic  sector  key indicators  user interest  market cap  industry premium stocks by name  ticker  star rating  market cap  stock type  sector  industry premium mutual funds by star rating  investment style  total assets  category  top holdings  top sectors  symbol  ticker  name premium etfs by star rating  category  total assets  symbol  ticker  name popular articles by title  date  author  collection  interest  popularity popular investment categories by topic  sector  key indicators  user interest  market cap  industry independent insightful trusted morningstar provides stock market analysis equity mutual fund and etf research ratings and picks portfolio tools and option hedge fund ira k and  plan research our reliable data and analysis can help both experienced enthusiasts and newcomers  copyright morningstar inc all rights reserved please read our terms of useand privacy policydow jones industrial average sp  nasdaq and morningstar index market barometer quotes are realtime russell  quote is  minutes delayed regeneron pharmaceuticals nasdaqregn news  analysis regeneron pharmaceuticals company profile nasdaqregn company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about regeneron pharmaceuticals nasdaqregn regeneron pharmaceuticals inc is a biopharmaceutical company that discovers invents develops manufactures and commercializes medicines for the treatment of serious medical conditions the company commercializes medicines for eye diseases high lowdensity lipoprotein ldl cholesterol and an inflammatory condition and have product candidates in development in other areas including rheumatoid arthritis asthma atopic dermatitis pain cancer and infectious diseases the companys marketed products include eylea aflibercept injection praluent alirocumab injection arcalyst rilonacept injection for subcutaneous use kevzara sarilumab solution for subcutaneous injection and zaltrap zivaflibercept injection for intravenous infusion as of december   the company had  product candidates in clinical development which consisted of a trapbased clinical program and  fully human monoclonal antibody product candidates industry sector and symbol sector medical industry bio therapeutic drugs subindustry biotechnology symbol nasdaqregn cusip f web wwwregeneroncom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book  profitabilityebidta  billionnet margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  shsbeta short ratio    frequently asked questions for regeneron pharmaceuticals nasdaqregn what is regeneron pharmaceuticals stock symbol regeneron pharmaceuticals trades on the nasdaq under the ticker symbol regn how were regeneron pharmaceuticals earnings last quarter regeneron pharmaceuticals inc nasdaqregn issued its quarterly earnings data on thursday may th the company reported  eps for the quarter beating the thomson reuters consensus estimate of  by  the business earned  billion during the quarter compared to the consensus estimate of  billion regeneron pharmaceuticals had a net margin of  and a return on equity of  the firms revenue was up  compared to the same quarter last year during the same quarter in the prior year the firm earned  eps view regeneron pharmaceuticals earnings history when will regeneron pharmaceuticals make its next earnings announcement regeneron pharmaceuticals is scheduled to release their next quarterly earnings announcement on wednesday august nd  view earnings estimates for regeneron pharmaceuticals where is regeneron pharmaceuticals stock going where will regeneron pharmaceuticals stock price be in   analysts have issued month price targets for regeneron pharmaceuticals shares their forecasts range from  to  on average they expect regeneron pharmaceuticals share price to reach  in the next year view analyst ratings for regeneron pharmaceuticals what are analysts saying about regeneron pharmaceuticals stock here are some recent quotes from research analysts about regeneron pharmaceuticals stock  according to zacks investment research regeneron’s key growth driver eylea continues to drive revenues and the company is expanding the drugs label for additional indications the fda’s approval of dupixent was a major boost to the company’s portfolio and regeneron is evaluating the drug for additional indications like asthma the approval of kevzara sarilumab for the treatment of moderatelytoseverely active rheumatoid arthritis both in the usand eu will further diversify the company’s portfolio on the other hand although sales of praluent have failed to impress due to the present payer utilization management restrictions in the us and limited market access in europe the drug is expected to have blockbuster potential shares of the company have also outperformed the industry in the year so far   cowen and company analysts commented regn reported q us   bmo capital markets analysts commented we raise our price target to  but maintain our market perform rating on regn following dupixent approval in adult atopic dermatitis while the approval was widely expected and reflects the strength of dupixents clinical profile we believe the k gross price k net is higher than expected bmo k prior and could lead to even more aggressive management by payors thus while we have updated our model to reflect dupixents actual price we have slowed our ramp on our expectation for increased access restrictions given the therapys high price   robert w baird analysts commented we surveyed  dermatologists treating  moderatetosevere ad patients each on their expectations around the launches for pfizers eucrisa and regeneronsanofis dupixent set for approval tomorrow docs highlighted the significant need for new mechanisms and therapeutic alternatives importantly physician sentiment points to a market for dupixent of about  patients in line with managements expectations we wouldnt be surprised to see an exceptionally strong launch here but we continue to point out that consensus expectations are already building that in  who are some of regeneron pharmaceuticals key competitors some companies that are related to regeneron pharmaceuticals include celgene corporation celg gilead sciences gild vertex pharmaceuticals incorporated vrtx exelixis exel tesaro tsro bioverativ bivv kite pharma kite neurocrine biosciences nbix bluebird bio blue clovis oncology clvs intercept pharmaceuticals icpt juno therapeutics juno ultragenyx pharmaceutical rare gw pharmaceuticals plc gwph agios pharmaceuticals agio beigene bgne china biologic products cbpo and prothena corporation plc prta who are regeneron pharmaceuticals key executives regeneron pharmaceuticals management team includes the folowing people p roy vagelos md chairman of the boardleonard s schleifer md phd president chief executive officer directorrobert e landry chief financial officer senior vice president  financedaniel p van plew executive vice president general manager  industrial operations and product supplyneil stahl phd executive vice president  research and developmentrobert j terifay executive vice president  commercialjoseph j larosa senior vice president general counsel secretarymichael aberman md senior vice president  strategy and investor relationpeter powchik md senior vice president  clinical developmentgeorge d yancopoulos md phd president and chief scientific officer  regeneron director who owns regeneron pharmaceuticals stock regeneron pharmaceuticals stock is owned by many different of retail and institutional investors top institutional shareholders include manning  napier advisors llc  russell investments group ltd  rockefeller financial services inc  chevy chase trust holdings inc  national pension service  and bank of montreal can  company insiders that own regeneron pharmaceuticals stock include arthur f ryan charles a baker douglas s mccorkle george yancopoulos joseph l goldstein michael s aberman michael s brown neil stahl p roy vagelos peter powchik plew daniel p van robert j terifay and sanofi view institutional ownership trends for regeneron pharmaceuticals who sold regeneron pharmaceuticals stock who is selling regeneron pharmaceuticals stock regeneron pharmaceuticals stock was sold by a variety of institutional investors in the last quarter including manning  napier advisors llc rockefeller financial services inc apg asset management nv russell investments group ltd bank of montreal can oakbrook investments llc exxonmobil investment management inc tx and cypress asset management inc tx company insiders that have sold regeneron pharmaceuticals stock in the last year include arthur f ryan charles a baker joseph l goldstein michael s aberman michael s brown neil stahl p roy vagelos and robert j terifay view insider buying and selling for regeneron pharmaceuticals who bought regeneron pharmaceuticals stock who is buying regeneron pharmaceuticals stock regeneron pharmaceuticals stock was purchased by a variety of institutional investors in the last quarter including chevy chase trust holdings inc barometer capital management inc mn services vermogensbeheer bv aperio group llc national pension service deane retirement strategies inc sheets smith wealth management and acadian asset management llc view insider buying and selling for regeneron pharmaceuticals how do i buy regeneron pharmaceuticals stock shares of regeneron pharmaceuticals can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is regeneron pharmaceuticals stock price today one share of regeneron pharmaceuticals stock can currently be purchased for approximately  marketbeat community rating for regeneron pharmaceuticals nasdaq regncommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about regeneron pharmaceuticals and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for regeneron pharmaceuticals nasdaqregn how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratings  buy ratingsconsensus ratinghold score consensus price target   downside analysts ratings history for regeneron pharmaceuticals nasdaqregn show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsbarclays plcreiterated ratingequal weight  lowbmo capital marketsreiterated ratingmarket perform  lowbank of america corporationreiterated ratingbuy  lowcredit suisse groupdowngradeholdlowmorgan stanleyreiterated ratingequal weight  mediumbtig researchreiterated ratingbuy  buy  highleerink swannreiterated ratingoutperform  lowsanford c bernsteindowngradeoutperform  market perform  lowraymond james financial increiterated ratingoutperform  mediumcanaccord genuityset price targetbuylowpiper jaffray companiesboost price targetoverweight  overweight  lowoppenheimer holdings increiterated ratingholdlowcowen and companyreiterated ratingholdlowjefferies group llcreiterated ratingholdlowrobert w bairdreiterated ratingneutrallowcibcinitiated coveragemarket perform  market performlowgoldman sachs group inc thedowngradebuy  neutralnacitigroup increiterated ratingbuynaj p morgan chase  coset price targetholdnawells fargo  companyreiterated ratingmarket performnaevercore isiset price targetholdnaroyal bank of canadareiterated ratingoutperform  nachardan capitallower price targetneutral  naargusreiterated ratingbuynaroth capitalset price targetbuynabrean capitalreiterated ratingbuynasuntrust banks inclower price targetneutral  nagabelliinitiated coveragebuynadeutsche bank agreiterated ratingbuy  nadata available from  forward earnings earnings history for regeneron pharmaceuticals nasdaqregnearnings history by quarter for regeneron pharmaceuticals nasdaq regndatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetails        q  billion billionviewlistenq  billion billionviewlistenq billion billionviewnaq billion billionviewnaq billion billionviewnaq billion billionviewlistenq billion billionviewlistenq million millionviewlistenq million millionviewnaq million millionviewnaq million millionviewnaq million millionviewnaq million millionviewnaq million millionviewnaq million millionviewnaq  million millionviewnaq  million millionviewnaq  million millionviewnaviewnaviewnaviewnaviewnaviewnadata available from  forward estimates earnings estimates for regeneron pharmaceuticals nasdaqregncurrent year eps consensus estimate  epsnext year eps consensus estimate  eps dividends dividend history for regeneron pharmaceuticals nasdaqregnno dividend announcements for this company have been tracked by marketbeatcom insider trades insider trading and institutional ownership history for regeneron pharmaceuticals nasdaqregninsider ownership percentage institutional ownership percentage insider trades by quarter for regeneron pharmaceuticals nasdaqregntransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailsmichael s abermansvpsell  neil stahlevpsell  michael s browndirectorsell  robert j terifayevpsell  neil stahlevpsell  joseph l goldsteindirectorsell  neil stahlevpsell  sanofimajor shareholderbuy  p roy vageloschairmansell  michael s browndirectorsell  michael s browndirectorsell  sanofimajor shareholderbuy  charles a bakerdirectorsell  arthur f ryandirectorsell  joseph l goldsteindirectorsell  joseph l goldsteindirectorsell  sanofimajor shareholderbuy  arthur f ryandirectorsell  plew daniel p vanevpsell  joseph l goldsteindirectorsell  joseph l goldsteindirectorsell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  douglas s mccorklevpsell  michael s browndirectorsell  george yancopoulosinsidersell  p roy vageloschairmansell  plew daniel p vansvpsell  neil stahlevpsell  p roy vageloschairmansell  george yancopoulosinsidersell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  michael s browndirectorsell  charles a bakerdirectorsell  peter powchiksvpsell  joseph l goldsteindirectorsell  joseph l goldsteindirectorsell  robert alexander ingramdirectorsell  plew daniel p vansvpsell  douglas s mccorklevpsell  joseph l goldsteindirectorsell  michael s browndirectorsell  charles a bakerdirectorsell  michael s abermansvpsell  michael s abermansvpsell  robert j terifaysvpsell  joseph j larosasvpsell  douglas s mccorklevpsell  marc tessierlavignedirectorsell  robert j terifaysvpsell  plew daniel p vansvpsell  joseph l goldsteindirectorsell  michael s abermansvpsell  leonard s schleiferceosell  peter powchiksvpsell  sanofimajor shareholderbuy  douglas s mccorklevpsell  alfred g gilmandirectorsell  neil stahlsvpsell  robert j terifaysvpsell  plew daniel p vansvpsell  joseph l goldsteindirectorsell  leonard s schleiferceosell  leonard s schleiferceosell  michael s browndirectorsell  murray a goldbergsvpsell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  p roy vageloschairmansell  joseph l goldsteindirectorsell  michael s abermanvpsell  douglas s mccorklevpsell  michael s browndirectorsell  joseph l goldsteindirectorsell  p roy vageloschairmansell  neil stahlsvpsell  p roy vageloschairmansell  neil stahlsvpsell  plew daniel p vansvpsell  joseph l goldsteindirectorsell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  plew daniel vansvpsell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  charles bakerdirectorsell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  michael browndirectorsell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  michael browndirectorsell  joseph goldsteindirectorsell  murray goldbergsvpsell  alfred gilmandirectorsell  murray goldbergsvpsell  joseph goldsteindirectorsell  michael abermanvpsell  robert terifaysvpsell  neil stahlsvpsell  george yancopoulosinsidersell  joseph goldsteindirectorsell  alfred gilmandirectorsell  douglas mccorklevpsell  p roy vageloschairmansell  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  sanofimajor shareholderbuy  alfred gilmandirectorsell  douglas mccorklevpsell  peter powchiksvpsell  peter powchiksvpsell  george singdirectorsell  joseph goldsteindirectorsell  leonard schleiferceosell  p roy vageloschairmansell  plew daniel vansvpsell  william robertsvpsell  leonard s schleiferceosell  joseph goldsteindirectorsell  charles a bakerdirectorsell  arthur f ryandirectorsell  joseph l goldsteindirectorsell  murray a goldbergcfosell  michael s browndirectorsell  michael s abermanvpsell  neil stahlsvpsell  george l singdirectorsell  robert j terifaysvpsell  p roy vageloschairmansell  p roy vageloschairmansell  charles a bakerdirectorsell  michael s browndirectorsell  arthur f ryandirectorsell  charles a bakerdirectorsell  george l singdirectorsell  data available from  forward headlines headline trends for regeneron pharmaceuticals nasdaqregn latest headlines for regeneron pharmaceuticals nasdaqregn source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineprotrader daily featured company news  regeneron and sanofi receive positive chmps opinion for dupixentrwwwfinanznachrichtende  july  at  pmfeatured company news  regeneron and sanofi receive positive chmps opinion for dupixentrfinanceyahoocom  july  at  pmregeneron pharmaceuticals inc regn given equal weight rating at barclays plcwwwamericanbankingnewscom  july  at  pmtesla moves up in market cap rank passing regeneron pharmaceuticals  nasdaqwwwnasdaqcom  july  at  amsanofi and regeneron receive positive chmp opinion for dupixent® dupilumab to treat adult patients with moderatetosevere atopic dermatitisfinanceyahoocom  july  at  amregeneron pharmaceuticals nasdaqregn market perform rating reaffirmed at bmo capital marketswwwamericanbankingnewscom  july  at  pmregeneron pharmaceuticals inc regn given buy rating at bank of america corporationwwwamericanbankingnewscom  july  at  pm big stock charts for thursday tripadvisor inc trip regeneron pharmaceuticals inc regn and lam research   investorplacecominvestorplacecom  july  at  amstocks end tightly mixed these  drugmakers prop nasdaq sp financeyahoocom  july  at  am big stock charts for thursday tripadvisor inc trip regeneron pharmaceuticals inc regn and lam research corporation lrcxinvestorplacecom  july  at  pmcredit suisse group lowers regeneron pharmaceuticals inc nasdaqregn to holdwwwamericanbankingnewscom  july  at  pmregeneron to report second quarter  financial and operating results and host conference call and webcast on august  financeyahoocom  july  at  amregeneron announces the  winners of the regeneron prize for creative innovationfinanceyahoocom  july  at  amzacks brokerages anticipate regeneron pharmaceuticals inc regn will post quarterly sales of  billionwwwamericanbankingnewscom  july  at  amregeneron pharmaceuticals inc nasdaqregn rating reiterated by morgan stanleywwwamericanbankingnewscom  july  at  pm earnings per share expected for regeneron pharmaceuticals inc regn this quarterwwwamericanbankingnewscom  july  at  pmregeneron pharmaceuticals inc nasdaqregn downgraded by bidaskclub to buywwwamericanbankingnewscom  july  at  pmzacks investment research lowers regeneron pharmaceuticals inc regn to holdwwwamericanbankingnewscom  july  at  pmregeneron pharmaceuticals inc nasdaqregn given consensus rating of hold by brokerageswwwamericanbankingnewscom  july  at  pmleerink swann reaffirms outperform rating for regeneron pharmaceuticals inc nasdaqregnwwwamericanbankingnewscom  july  at  pmregeneron price target boosted at btig  seeking alphaseekingalphacom  july  at  amcorporate news blog  regeneron and sanofi announced kevzara approval by the european commissionfinanceyahoocom  july  at  amnike micron regeneron get price target hikes walgreens is a buyfinanceyahoocom  july  at  amregeneron pharmaceuticals inc regn pt raised to wwwamericanbankingnewscom  june  at  amnoteworthy thursday option activity sig met regn  nasdaqwwwnasdaqcom  june  at  amstrongbridge sbbp shows strength stock moves up financeyahoocom  june  at  amamgen gets positive chmp opinion for mimpara label expansionfinanceyahoocom  june  at  pmsanofiregenerons kevzara gets marketing approval in eufinanceyahoocom  june  at  pmregeneron the more the merrierfinanceyahoocom  june  at  pmregeneron pharmaceuticals has a powerful base pattern but looks extendedfinanceyahoocom  june  at  pmdow component merck fails to impress with cholesterolbusting drugfinanceyahoocom  june  at  pmregeneron ec okays kevzara to treat moderately to severely active rawwwnasdaqcom  june  at  amregeneron and sanofi announce approval of kevzara® sarilumab to treat adult wwwprnewswirecom  june  at  amis it time to step to the sidelines on regeneronfinanceyahoocom  june  at  amregeneron and sanofi announce approval of kevzara® sarilumab to treat adult patients with moderately to severely active rheumatoid arthritis in the european unionfinanceyahoocom  june  at  amsanofi and regeneron announce approval of kevzara® sarilumab to treat adult patients with moderately to severely active rheumatoid arthritis in the european unionfinanceyahoocom  june  at  amregeneron pharmaceuticals inc regn downgraded by sanford c bernsteinwwwamericanbankingnewscom  june  at  pmregeneron pharmaceuticals inc regn rating increased to strongbuy at bidaskclubwwwamericanbankingnewscom  june  at  pmregeneron regn details royalty agreement with novartis for acz  streetinsidercomwwwstreetinsidercom  june  at  amregeneron regn stock on fire whats behind the surgewwwzackscom  june  at  pmregeneron regn stock on fire whats behind the surgefinanceyahoocom  june  at  pmbiotech movers regeneron slides back after big gainsfinanceyahoocom  june  at  pmsonic forestar post gains blackberry regeneron fallfinanceyahoocom  june  at  pmmichael s aberman sells  shares of regeneron pharmaceuticals inc regn stockwwwamericanbankingnewscom  june  at  pminsider selling regeneron pharmaceuticals inc regn evp sells  shares of stockwwwamericanbankingnewscom  june  at  pmstock traders purchase large volume of put options on regeneron pharmaceuticals regnwwwamericanbankingnewscom  june  at  pmus stocks slip in early tradingwwwlatimescom  june  at  amregeneron regn details royalty agreement with novartis for aczwwwstreetinsidercom  june  at  ambriefregeneron details royalty agreement with novartis for canakinumabwwwreuterscom  june  at  amregeneron details royalty agreement with novartis for canakinumab aczfinanceyahoocom  june  at  am social chart regeneron pharmaceuticals regn chart for tuesday july   this page was last updated on  by marketbeatcom staff ﻿ manning  napier advisors llc lowers stake in regeneron pharmaceuticals inc regn  bnb daily daily ratings  news for regeneron pharmaceuticals inc complete the form below to receive the latest headlines and analysts recommendationsfor regeneron pharmaceuticals inc with our free daily email newsletter follow bnbdailynews recent posts bp plc nysebp shares sold by thomas white international ltd beutel goodman  co ltd sells  shares of toronto dominion bank the td omnova solutions nyseomn earning somewhat negative press coverage study shows turkcell iletisim hizmetleri as nysetkc earning somewhat critical press coverage analysis finds athersys nasdaqathx getting somewhat critical news coverage accern reports ocata therapeutics nasdaqocat receiving negative media coverage accern reports peak resorts nasdaqskis receiving critical press coverage report finds tiaa cref investment management llc has  million stake in valmont industries inc vmi teachers advisors llc has  million stake in intuitive surgical inc isrg teachers advisors llc has  million position in american international group inc aig tiaa cref investment management llc raises position in south state corporation ssb the york water company nasdaqyorw declares  quarterly dividend zacks brokerages expect weibo corporation wb will post earnings of  per share costamare inc cmre given average recommendation of “hold” by analysts brokerages set kinaxis inc kxs target price at   eps expected for haverty furniture companies inc hvt this quarter research analysts offer predictions for schroders plc’s fy earnings otcshnwf wacker chemie ag’s wch buy rating reaffirmed at dz bank ag marsh  mclennan companies mmc receiving somewhat favorable media coverage report finds park hotels  resorts inc nysepk receives  average target price from analysts manning  napier advisors llc lowers stake in regeneron pharmaceuticals inc regn posted by tim parker on jul nd   no comments manning  napier advisors llc lowered its stake in regeneron pharmaceuticals inc nasdaqregn by  during the second quarter according to its most recent f filing with the securities and exchange commission the firm owned  shares of the biopharmaceutical company’s stock after selling  shares during the period regeneron pharmaceuticals makes up  of manning  napier advisors llc’s holdings making the stock its th largest position manning  napier advisors llc owned approximately  of regeneron pharmaceuticals worth  as of its most recent sec filing a number of other hedge funds and other institutional investors also recently modified their holdings of regn alpha windward llc increased its position in shares of regeneron pharmaceuticals by  in the second quarter alpha windward llc now owns  shares of the biopharmaceutical company’s stock valued at  after buying an additional  shares during the period concert wealth management inc increased its position in shares of regeneron pharmaceuticals by  in the first quarter concert wealth management inc now owns  shares of the biopharmaceutical company’s stock valued at  after buying an additional  shares during the period cleararc capital inc increased its position in shares of regeneron pharmaceuticals by  in the first quarter cleararc capital inc now owns  shares of the biopharmaceutical company’s stock valued at  after buying an additional  shares during the period sheaff brock investment advisors llc increased its position in shares of regeneron pharmaceuticals by  in the first quarter sheaff brock investment advisors llc now owns  shares of the biopharmaceutical company’s stock valued at  after buying an additional  shares during the period finally grandfield  dodd llc increased its position in shares of regeneron pharmaceuticals by  in the first quarter grandfield  dodd llc now owns  shares of the biopharmaceutical company’s stock valued at  after buying an additional  shares during the period institutional investors and hedge funds own  of the company’s stock get regeneron pharmaceuticals inc alerts shares of regeneron pharmaceuticals inc nasdaq regn traded down  during midday trading on friday reaching  the company’s stock had a trading volume of  shares the firm has a day moving average of  and a day moving average of  regeneron pharmaceuticals inc has a one year low of  and a one year high of  the stock has a market cap of  billion a pe ratio of  and a beta of  regeneron pharmaceuticals nasdaqregn last posted its quarterly earnings data on thursday may th the biopharmaceutical company reported  earnings per share for the quarter topping the thomson reuters’ consensus estimate of  by  regeneron pharmaceuticals had a return on equity of  and a net margin of  the business had revenue of  billion for the quarter compared to analysts’ expectations of  billion during the same quarter in the previous year the firm earned  earnings per share the business’s revenue was up  on a yearoveryear basis on average analysts forecast that regeneron pharmaceuticals inc will post  eps for the current year trademark violation notice “manning  napier advisors llc lowers stake in regeneron pharmaceuticals inc regn” was originally posted by bnb daily and is the property of of bnb daily if you are viewing this piece on another site it was illegally copied and republished in violation of united states and international copyright  trademark law the correct version of this piece can be viewed at httpswwwbaseballnewsblogcommanningnapieradvisorsllclowersstakeinregeneronpharmaceuticalsincregnhtml several brokerages recently issued reports on regn ubs ag upped their price target on shares of regeneron pharmaceuticals from  to  and gave the stock a “buy” rating in a research report on wednesday march th bank of america corporation reissued a “buy” rating and set a  price objective up from  on shares of regeneron pharmaceuticals in a report on friday bmo capital markets reissued a “market perform” rating and set a  price objective up from  on shares of regeneron pharmaceuticals in a report on friday piper jaffray companies boosted their price objective on regeneron pharmaceuticals from  to  and gave the stock an “overweight” rating in a report on tuesday june th finally cowen and company reissued a “hold” rating and set a  price objective on shares of regeneron pharmaceuticals in a report on monday may th one equities research analyst has rated the stock with a sell rating sixteen have issued a hold rating and thirteen have given a buy rating to the company regeneron pharmaceuticals presently has a consensus rating of “hold” and an average target price of  in other regeneron pharmaceuticals news chairman p roy vagelos sold  shares of the business’s stock in a transaction on thursday may th the stock was sold at an average price of  for a total value of  following the transaction the chairman now owns  shares of the company’s stock valued at  the transaction was disclosed in a legal filing with the sec which can be accessed through the sec website also svp michael s aberman sold  shares of the business’s stock in a transaction on thursday june nd the stock was sold at an average price of  for a total value of  following the completion of the transaction the senior vice president now directly owns  shares in the company valued at approximately  the disclosure for this sale can be found here in the last three months insiders sold  shares of company stock worth  insiders own  of the company’s stock about regeneron pharmaceuticals regeneron pharmaceuticals inc is a biopharmaceutical company that discovers invents develops manufactures and commercializes medicines for the treatment of serious medical conditions the company commercializes medicines for eye diseases high lowdensity lipoprotein ldl cholesterol and an inflammatory condition and have product candidates in development in other areas including rheumatoid arthritis asthma atopic dermatitis pain cancer and infectious diseases receive news  ratings for regeneron pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for regeneron pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website michaels stores – art supplies crafts  framing menu my cart  sign in  register create an account sign in  register stores arrow choose your country united states canada  english canada  french canada coupons blog email sign up arrow join our email list get the latest on trends deals and promotions enter your email sign up click to chat michaels rewards sign in  register free shipping on online orders   details free shipping on online orders   details no promo code requiredmust select ground shipping at checkoutoversize charges may apply valid thru sat  coupon policy  shipping policy stock up for back to school prismacolor® scholar™ colored pencils    set acrylic paint set by artists loft®   create ® the classic happy planner®  month student edition box kit happy plans   free cover with the purchase of a planner strathmore®  series sketch pad    buy one get one  off crayola® boxed crayons ct  buy one get one  off recollections™ storage desktop carousel   gildan® short sleeve youth tshirt   freeshipping brother™ cm scanncut  cutting machine  scanner   iris® scrapbook case   artists loft® super value canvas pack  x   recollections™  drawer rolling organizer  sharpie® color burst fine point permanent markers  elmers® washable school glue  gallon  planner washi tape box by recollections™  buy one get one  off washable tempera paint by artminds®  ‹ › featured projects see all projects  painted sentiment rocks check it out cactus bulletin board check it out pom pom rug check it out painted glass floral vases check it out friyay tote check it out st day of school chalkboard check it out dorm room rain cloud pillow check it out slime classroom door décor check it out paint splatter tshirt check it out dorm room pom pom mirror check it out ‹ › shop categories art supplies baking  party beads  jewelry canvas crafts  hobbies floral  decor frames kids knitting  crochet organization  storage papercraft sewing  fabric seasonal wedding your browsers javascript functionality is turned off please turn it on so that you can experience the full capabilities of this site michael r aberman  chicago il  intelius sign in we found michael r aberman in chicago il michael r aberman intelius found that michael r aberman is a male between  and  years old from chicago il we have connected them to  addresses  phones and  relatives or associates also known as michael c ackerman michael l aberman get report now age michael r aberman is in his s michael has lived in chicago il buffalo grove il new york ny michaels relatives tracy aberman sheldon aberman sandra aberman david aberman michael r aberman zodiac signleo gendermale professional status design director at aspen art museum get report now want to know more about michael get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about michael or use our people search engine to find others get background check on michael r aberman get a criminal check on michael r aberman get a public record report on michael r aberman get a people search report on michael r aberman michael r abermans contact information known cities lived in find out where michael r aberman has lived as well as michael r abermans phone numbers and email addresses michael r aberman has lived in  states illinois address for michael r aberman  w a a chicago il has lived in chicago il buffalo grove il get full address report phone numbers associated with michael r aberman    chicago il    new york ny    new york ny get full phone report email addresses associated with michael r aberman alnet recom mnnet get email report michael r abermans education information known schools attended learn about michael r abermans academic history find out which schools michael r aberman attended the dates attended as well as the degrees michael r aberman received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act michael r aberman has attended  schools minneapolis college of art and design  –  michael r aberman has a bfa graphic design in graphic design minneapolis college of art and design  –  michael r aberman has a bfa in graphic design minneapolis college of art and design  –  michael r aberman has a bfa graphic design in graphic design michael r abermans professional information information regarding michael r abermans professional history find out previous places michael r aberman has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act michael r aberman has worked at  places company aspen art museum title design director company aspen art museum title graphic designer michael r abermans experience title design director company aspen art museum job details the aspen art museum is a noncollecting institution presenting the newest most important evolutions in international contemporary art our innovative and timely exhibitions education and public programs immersive activities and community happenings actively engage audiences in thoughtprovoking experiences of art culture and society title graphic designer company aspen art museum job details the aspen art museum is a noncollecting institution presenting the newest most important evolutions in international contemporary art our innovative and timely exhibitions education and public programs immersive activities and community happenings actively engage audiences in thoughtprovoking experiences of art culture and society additional professional information on michael r aberman see michael r abermans linkedin profile michael r abermans social network and potential email matches find out potential social network profiles and potential email usernamed for michael r aberman michael r abermans known social networks and potential email matches find all of michael r abermans social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches michael aberman username matches michaelaberman abermanmichael michaelaberman abermanmichael michaelaberman abermanmichael michaelaberman abermanmichael maberman popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches m aberman intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming check for social media accounts this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip